Literature DB >> 15589826

Identification and characterization of D8C, a novel domain present in liver-specific LZP, uromodulin and glycoprotein 2, mutated in familial juvenile hyperuricaemic nephropathy.

Huirong Yang1, Chaoqun Wu, Shouyuan Zhao, Jinhu Guo.   

Abstract

Present work reported a novel domain--D8C (domain with conserved eight cysteines in liver-specific ZP domain-containing protein, glycoprotein 2 (GP-2) and uromodulin (UMOD)), present in liver-specific LZP, UMOD, GP-2 and some uncharacterized proteins, most of which are membrane proteins, extracellular proteins or nuclear membrane proteins. D8C contains eight well-conserved cysteine residues, which were predicted to form four pairs of disulfide bridges. D8C is composed mainly of beta-strands. Mutation in the D8C at Cys217 in human UMOD is associated with familial juvenile hyperuricaemic nephropathy, which might be due to the disruption of the disulfide bridge. Identification of D8C would further the understandings of related proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589826     DOI: 10.1016/j.febslet.2004.10.092

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

2.  Molecular and cellular effects of Tamm-Horsfall protein mutations and their rescue by chemical chaperones.

Authors:  Lijie Ma; Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

3.  Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model.

Authors:  Wei-Zhong Ying; Christopher E Allen; Lisa M Curtis; Kristal J Aaron; Paul W Sanders
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

Review 4.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

5.  A novel UMOD mutation (c.187T>C) in a Korean family with juvenile hyperuricemic nephropathy.

Authors:  Mi-Na Lee; Ji-Eun Jun; Ghee Young Kwon; Woo-Seong Huh; Chang-Seok Ki
Journal:  Ann Lab Med       Date:  2013-06-24       Impact factor: 3.464

6.  Point mutation in D8C domain of Tamm-Horsfall protein/uromodulin in transgenic mice causes progressive renal damage and hyperuricemia.

Authors:  Lijie Ma; Yan Liu; Nichole K Landry; Tarek M El-Achkar; John C Lieske; Xue-Ru Wu
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

7.  The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae.

Authors:  Su Yu; Anson W Lowe
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

8.  A structured interdomain linker directs self-polymerization of human uromodulin.

Authors:  Marcel Bokhove; Kaoru Nishimura; Martina Brunati; Ling Han; Daniele de Sanctis; Luca Rampoldi; Luca Jovine
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

9.  Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH.

Authors:  Alena Stsiapanava; Chenrui Xu; Shunsuke Nishio; Ling Han; Nao Yamakawa; Marta Carroni; Kathryn Tunyasuvunakool; John Jumper; Daniele de Sanctis; Bin Wu; Luca Jovine
Journal:  Nat Struct Mol Biol       Date:  2022-03-10       Impact factor: 15.369

10.  Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.

Authors:  Siân E Williams; Anita A C Reed; Juris Galvanovskis; Corinne Antignac; Tim Goodship; Fiona E Karet; Peter Kotanko; Karl Lhotta; Vincent Morinière; Paul Williams; William Wong; Patrik Rorsman; Rajesh V Thakker
Journal:  Hum Mol Genet       Date:  2009-05-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.